Stocks · Healthcare · Medical - Instruments & Supplies
Avantor, Inc. AVTR
$15.34 +2.06% Close, Oct 2, 2026 · NYSE · Market cap $10.38B
Strong trend
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-0.84, down 183.6% year over year.
- Operating margin narrowed to -4.4% from 15.6% a year earlier.
- Net debt is 27.1× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 28%
- EPS growth (TTM, YoY)Bottom 11%
- FCF growth (TTM, YoY)Bottom 26%
- Revenue growth, 3-year CAGRBottom 16%
- Revenue growth accelerationTop 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 35%
- Gross marginBottom 20%
- Operating marginTop 47%
- Accruals (lower is better)Top 34%
- Net debt / EBITDA (lower is better)Bottom 2%
- Interest coverTop 50%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 45%
- Free-cash-flow yieldTop 20%
- EBITDA / enterprise valueTop 35%
- Sales / enterprise valueTop 26%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 40%
- 6-month returnTop 9%
- 1-year return vs S&P 500Bottom 50%
- Distance from 52-week highTop 5%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 47%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 4%
- Upside to consensus price targetBottom 2%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 30%
- Maximum drawdown, 3 yearsBottom 46%
- Beta vs S&P 500 (lower is better)Top 37%
- Net debt / EBITDA (lower is better)Bottom 2%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -2.0% | -1.6% | ↑ |
| EPS growth (YoY) | -176.7% | -183.6% | ↓ |
| Gross margin | 33.2% | 31.8% | ↓ |
| Operating margin | 15.6% | -4.4% | ↓ |
| FCF margin | 8.3% | 6.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -1.6% | -2.0% | ↑ | Bottom 28% |
| EPS growth (TTM, YoY) | -183.6% | -176.7% | ↓ | Bottom 11% |
| Gross margin | 31.8% | 33.2% | ↓ | Bottom 20% |
| Operating margin | -4.4% | 15.6% | ↓ | Top 47% |
| Net margin | -8.8% | 10.3% | ↓ | — |
| Free-cash-flow margin | 6.9% | 8.3% | ↓ | — |
| Return on invested capital | -2.8% | — | Top 35% | |
| Revenue growth, 3-year CAGR | -4.5% | — | Bottom 16% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -10.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 27.06×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -1.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.72%
- Shareholder yield
- 0.72%
- Share count change, 1 year
- -0.7%
- Share count change, 3-year CAGR
- +0.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 29, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +5.1%
- Average 2-day reaction, last 8
- -8.6%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $11.67
- Target vs current price
- -23.9%
- Analysts with a rating
- 26
- Share rating Buy or Strong Buy
- 31%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +9.7% | +15.8% | +10.1% | +16.1% | — |
| Apr 29, 2026 | +8.3% | -0.1% | +2.4% | +6.9% | +45.5% |
| Feb 11, 2026 | +4.8% | -13.6% | -16.9% | -25.7% | -25.5% |
| Oct 29, 2025 | -2.1% | -23.2% | -23.2% | -21.4% | -21.8% |
| Aug 1, 2025 | -4.0% | -15.5% | -15.3% | -1.7% | +14.6% |
| Apr 25, 2025 | -0.6% | -16.6% | -16.4% | -17.0% | -16.0% |
| Feb 7, 2025 | +8.0% | -11.7% | -16.6% | -19.4% | -41.8% |
| Oct 25, 2024 | +2.1% | -3.6% | -3.9% | -12.5% | -6.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.21 | $0.19 | +9.7% | $1.69B |
| Apr 29, 2026 | $0.17 | $0.16 | +8.3% | $1.58B |
| Feb 11, 2026 | $0.22 | $0.21 | +4.8% | $1.66B |
| Oct 29, 2025 | $0.22 | $0.22 | -2.1% | $1.62B |
| Aug 1, 2025 | $0.24 | $0.25 | -4.0% | $1.68B |
| Apr 25, 2025 | $0.23 | $0.23 | -0.6% | $1.58B |
| Feb 7, 2025 | $0.27 | $0.25 | +8.0% | $1.69B |
| Oct 25, 2024 | $0.26 | $0.25 | +2.1% | $1.71B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 18.9× | — | — | — |
| EV / EBITDA | 109.9× | — | — | Top 35% |
| EV / Sales | 2.10× | — | — | Top 26% |
| Free-cash-flow yield | 4.38% | — | — | Top 20% |
| Earnings yield | -5.47% | — | — | Top 45% |
P/E over the past five years
Range 11.3× – 83.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +12.2%
- Earnings per share growth (TTM)
- -183.6%
- Change in P/E multiple
- -76.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 92
- Days above the 200-day average
- 61
- 50-day average slope (20 days)
- +14.8%
- 200-day average slope (20 days)
- +3.8%
- Distance from 50-day average
- +6.8%
- Distance from 200-day average
- +42.9%
- RSI (14)
- 58.1
- Relative volume
- 0.67×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 45.3%
- Volatility vs own 5-year history
- 75th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.91
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -3.3%
- Maximum drawdown, 3 years
- -73.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 24, 2021 | Mar 27, 2026 | -83.2% | 1130 days | Not yet recovered |
| Jan 25, 2021 | Mar 8, 2021 | -12.6% | 29 days | 20 days (Apr 6, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $10.38B
- EPS, diluted (TTM)
- -$0.84
- Revenue (TTM)
- $6.56B
- 52-week range
- $7.27 – $16.05
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $7.39B | $7.51B | $6.97B | $6.78B | $6.55B |
| Gross profit | $2.50B | $2.60B | $2.36B | $2.28B | $2.14B |
| Operating income | $972.2M | $1.13B | $696.4M | $1.08B | -$246.2M |
| Net income | $572.6M | $686.5M | $321.1M | $711.5M | -$530.2M |
| EPS (diluted) | $0.85 | $1.01 | $0.47 | $1.04 | -$0.78 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.69B | $1.58B | $1.68B | $1.62B | $1.66B | $1.58B | $1.69B |
| Net income | $57.8M | $500.4M | $64.5M | $64.7M | -$711.8M | $52.4M | $43.3M | $38.1M |
| EPS (diluted) | $0.08 | $0.73 | $0.09 | $0.09 | -$1.04 | $0.08 | $0.06 | $0.06 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $953.6M | $843.6M | $870.0M | $840.8M | $623.8M |
| Capital expenditure | -$111.1M | -$133.4M | -$146.4M | -$148.8M | -$128.8M |
| Free cash flow | $842.5M | $710.2M | $723.6M | $692.0M | $495.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $941.2M | -$13.2M | -$13.7M | -$8.6M | -$75.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $306.8M
- Total assets
- $11.60B
- Total liabilities
- $5.97B
- Total debt
- $3.70B
- Net debt
- $3.39B
- Shareholders’ equity
- $5.63B
As of Jun 30, 2026 (filed Jul 29, 2026).
Short interest
- Shares sold short
- 51,373,338
- Days to cover
- 6.19
- Change vs previous report
- +2.3%
FINRA short interest, settlement date Sep 15, 2026.